New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout
New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout

Hong Kong-listed cancer screening start-up New Horizon Health to leverage AstraZeneca’s marketing muscle in China push

  • ColoClear, the only such test approved in China, has a target market of 633 million people under the Chinese health authority’s screening recommendation
  • Firm to launch ColoClear in the city by June With the help of Hong Kong-based partner Prenetics

Topic |   Health & Fitness
New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout
New Horizon Health will focus its overseas expansion effort in Asia, especially in Southeast Asia, Japan and South Korea. Photo: Handout
READ FULL ARTICLE